Back

Learner’s Digest International (TM)

  • Asthma
  • Gastroesophageal Reflux
  • Somatostatin
  • Sublingual Immunotherapy
  • Vocal Cord Dysfunction

GERD, Laryngeal Disorders, and Vocal Cord Dysfunction/Sublingual Immunotherapy Tablets for Inhalant Allergies/Asthma

The goal of this program is to improve the management of gastroesophageal reflux disease (GERD), laryngeal disorders, and vocal cord dysfunction, use of sublingual immunotherapy (SLIT) tablets in patients with inhalant allergies, and treatment of respiratory comorbidities of asthma. After hearing and assimilating this program, the clinician will be better able to: 1. List symptoms associated with GERD. 2. Explain evidence regarding use of proton pump inhibitors in patients with asthma and GERD. 3. Recommend SLIT tablets for patients with inhalant allergies. 4. Diagnose allergic bronchopulmonary aspergillosis through assessment of IgE levels. 5. Use somatostatin analogue therapy in management of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

ABOHNS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Jul 7, 2028 2 years left